FDA.reportPublic FDA data

Application 205544

Type
ANDA
Sponsor
WILSHIRE PHARMS INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001NATEGLINIDENATEGLINIDETABLET;ORAL60MGNoNo
002NATEGLINIDENATEGLINIDETABLET;ORAL120MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
16571-758NATEGLINIDENATEGLINIDERising Pharmaceuticals, Inc.ANDACurrent
16571-758NATEGLINIDENATEGLINIDERising Pharma Holdings, Inc.ANDACurrent
16571-759NATEGLINIDENATEGLINIDERising Pharmaceuticals, Inc.ANDACurrent
16571-759NATEGLINIDENATEGLINIDERising Pharma Holdings, Inc.ANDACurrent
52536-063NateglinideNateglinideWilshire Pharmaceuticals, Inc.ANDACurrent
52536-067NateglinideNateglinideWilshire Pharmaceuticals, Inc.ANDACurrent